The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of somatic DNA repair mutations on bone-related efficacy endpoints in patients with metastatic castration-resistant prostate cancer (mCRPC): A retrospective analysis.
 
Maria Concetta Cursano
No Relationships to Disclose
 
Emilio Francesco Giunta
No Relationships to Disclose
 
Emanuela Scarpi
No Relationships to Disclose
 
Chiara Casadei
No Relationships to Disclose
 
Alessandra Virga
No Relationships to Disclose
 
Paola Ulivi
No Relationships to Disclose
 
Sara Bleve
No Relationships to Disclose
 
Nicole Brighi
No Relationships to Disclose
 
Giorgia Ravaglia
No Relationships to Disclose
 
Francesco Pantano
No Relationships to Disclose
 
Daniele Santini
Consulting or Advisory Role - Amgen; Ipsen; Janssen; Merck; MSD Oncology; Novartis; Roche; Sanofi
 
Vincenza Conteduca
Consulting or Advisory Role - Amgen; Astellas Oncology; AstraZeneca; Bayer HealthCare Pharmacuticals; Janssen; Merck
Speakers' Bureau - Astellas Oncology; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Sanofi
Travel, Accommodations, Expenses - Astellas Oncology; Astellas Oncology; Bayer; Bristol-Myers Squibb; Janssen; Sanofi
 
Ugo De Giorgi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Dompé Farmaceutici; Eisai; Ipsen; Janssen; Merck KGaA; MSD; Novartis; Pfizer; PharmaMar
Research Funding - AstraZeneca (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Ipsen; Pfizer